Feb 28 2023
GoodRx Reports Fourth Quarter and Full Year 2022 Results
Fourth quarter financial results exceed previously announced guidance SANTA MONICA, Calif. --(BUSINESS WIRE)--Feb. 28, 2023-- GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, has released its financial results for the fourth quarter and full year 2022.
PDF Version
Feb 21 2023
GoodRx to Present at the Cowen 43rd Annual Health Care Conference
SANTA MONICA, Calif. --(BUSINESS WIRE)--Feb. 21, 2023-- GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced that executives from the Company will be presenting at the Cowen 43 rd Annual Health Care Conference in Boston, MA on Tuesday, March 7, 2023 at 6:50
PDF Version
Feb 01 2023
GoodRx Response to FTC Settlement
SANTA MONICA, Calif.--(BUSINESS WIRE)--At GoodRx, protecting our users’ privacy is one of our most important priorities. We are thoughtful and disciplined about what information we gather and how and why we use it. The settlement with the FTC focuses on an old issue that was proactively addressed
PDF Version